Literature DB >> 27144870

Reevaluating PSA Testing Rates in the PLCO Trial.

Jonathan E Shoag1, Sameer Mittal1, Jim C Hu2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27144870     DOI： 10.1056/NEJMc1515131

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

1.  Reconsidering the Trade-offs of Prostate Cancer Screening.

Authors:  Jonathan E Shoag; Yaw A Nyame; Roman Gulati; Ruth Etzioni; Jim C Hu
Journal:  N Engl J Med       Date:  2020-06-18       Impact factor: 91.245

2.  A 24-year prospective study of dietary α-linolenic acid and lethal prostate cancer.

Authors:  Juan Wu; Kathryn M Wilson; Meir J Stampfer; Walter C Willett; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2018-01-23       Impact factor: 7.396

Review 3.  Prostate Cancer Screening.

Authors:  William J Catalona
Journal:  Med Clin North Am       Date:  2018-03       Impact factor: 5.456

4.  Impact of a Prostate Specific Antigen Screening Decision Aid on Clinic Function.

Authors:  Christopher A Warlick; Jerica M Berge; Yen-Yi Ho; Mark Yeazel
Journal:  Urol Pract       Date:  2017-11

Review 5.  Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.

Authors:  Ashwin A Kotwal; Mara A Schonberg
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

Review 6.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

7.  Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.

Authors:  Jim C Hu; Paul Nguyen; Jialin Mao; Joshua Halpern; Jonathan Shoag; Jason D Wright; Art Sedrakyan
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

Review 8.  Prostate Cancer Research at the Crossroads.

Authors:  Michael M Shen; Mark A Rubin
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

9.  [Gigerenzer and absolute percentages-an attempt at an evidence-based apostil].

Authors:  M Stöckle
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

10.  Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Guidelines.

Authors:  Navin Shah; Vladimir Ioffe; Thomas Huebner; Ivelina Hristova
Journal:  Rev Urol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.